Variation in KLK genes, prostate-specific antigen and risk of prostate cancer

Article metrics

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Associations of tag SNPs in the KLK region with PSA concentrations and prostate cancer risk in the PLCO Trial.


  1. 1

    Eeles, R.A. et al. Nat. Genet. 40, 316–321 (2008).

  2. 2

    Pal, P. et al. Hum. Genet. 122, 251–259 (2007).

  3. 3

    Lai, J. et al. Carcinogenesis 28, 1032–1039 (2007).

  4. 4

    Cramer, S.D. et al. J. Natl. Cancer Inst. 95, 1044–1053 (2003).

  5. 5

    Prorok, P.C. et al. Control. Clin. Trials 21, 273S–309S (2000).

  6. 6

    Thomas, G. et al. Nat. Genet. 40, 310–315 (2008).

  7. 7

    Borgono, C.A. et al. Mol. Cancer Res. 2, 257–280 (2004).

  8. 8

    Woolf, S.H. N. Engl. J. Med. 333, 1401–1405 (1995).

  9. 9

    de Koning, H.J. et al. Int. J. Cancer 98, 268–273 (2002).

  10. 10

    Nam, R.K. et al. J. Clin. Oncol. 21, 2312–2319 (2003).

Download references


The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and by contracts from the Division of Cancer Prevention, National Cancer Institute (NCI), US National Institutes of Health (NIH), Department of Health and Human Services (DHHS). The Health Professionals Follow-up Study (HPFS) study is supported by NIH grants CA55075 and U01CA098233. The American Cancer Society (ACS) study is supported by U01 CA098710. The Alpha Tocopherol Beta-Carotene Cancer Prevention (ATBC) Study is supported by the Intramural Research Program of the National Cancer Institute, NIH, and by US Public Health Service contracts N01-CN-45165, N01-RC-45035 and N01-RC-37004 from the National Cancer Institute, NIH, DHHS. A.S.K is supported by RO1CA112028. The genome-wide scans have been supported by the NCI, NIH, under contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the DHHS, nor does mention of trade names, commercial products or organizations imply endorsement by the US government.

Author information

Correspondence to Richard B Hayes.

Supplementary information

Supplementary Text and Figures

Supplementary Figure 1, Supplementary Tables 1–6, Supplementary Methods (PDF 418 kb)

Rights and permissions

Reprints and Permissions

About this article

Further reading